AxiaLIF
Commercial- Indications
- Degenerative disc disease, Lower lumbar spine disorders
Company intelligence / Profile preview
Ascension Orthopedics developed and commercialized a portfolio of innovative orthopedic implants, particularly for upper and lower limb small-joint replacements. Its products included pyrolytic carbon total joint replacements for the hand, as well as implants for the shoulder, elbow, wrist, foot, and ankle. The company’s technologies were supported by decades of clinical data on durability and biocompatibility. In 2011, it was acquired by Integra LifeSciences Holdings Corporation for approximately $65 million in cash to expand Integra's presence in the extremities market.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ascension Orthopedics.